Besides, FAM83D can advance epithelial-mesenchymal transition and metastasis of non-small cell lung carcinoma cells through the AKT/mTOR signal pathway, also improve the sensitivity of NSCLC cells to cisplatin [42]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.